RELENZA

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

ZANAMIVIR MICRONIZED

Disponible desde:

GLAXO SMITH KLINE (ISRAEL) LTD

Código ATC:

J05AH01

formulario farmacéutico:

POWDER FOR INHALATION

Composición:

ZANAMIVIR MICRONIZED 5 MG

Vía de administración:

INHALATION

tipo de receta:

Required

Fabricado por:

GLAXO SMITH KLINE AUSTRALIA PTY LTD

Grupo terapéutico:

ZANAMIVIR

Área terapéutica:

ZANAMIVIR

indicaciones terapéuticas:

Zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza A and B virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.

Fecha de autorización:

2017-03-26